O6-alkylguanine-DNA-alkyltransferase modulation study Fotemustine plus Temozolomide phase I/II .
Latest Information Update: 01 Jun 2011
At a glance
- Drugs Fotemustine (Primary) ; Temozolomide (Primary)
- Indications Malignant melanoma
- Focus Adverse reactions; Therapeutic Use
- 01 Jun 2011 New trial record